AAAAAA

   
Results: 1-10 |
Results: 10
STEROIDAL AROMATASE INHIBITOR IN ELDERLY PATIENTS
Authors: BAJETTA E ZILEMBO N POZZI P LATORRE I BICHISAO E
Citation: E. Bajetta et al., STEROIDAL AROMATASE INHIBITOR IN ELDERLY PATIENTS, Annals of oncology, 9, 1998, pp. 7-7
EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER
Authors: FERRARI L BAJETTA E SEREGNI E MARTINETTI A ZILEMBO N NOBERASCO C BUZZONI R BOTTI C MASSARON S BICHISAO E CELIO L BOMBARDIERI E
Citation: L. Ferrari et al., EFFECTS OF AROMATASE COMPLEX SELECTIVE-INHIBITION ON INSULIN-LIKE-GROWTH-FACTOR-1 AND INSULIN-LIKE-GROWTH-FACTOR BINDING-PROTEIN-3 CIRCULATING LEVELS IN BREAST-CANCER, International journal of oncology, 11(1), 1997, pp. 163-167
THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS
Authors: BAJETTA E FERRARI L CELIO L MARIANI L MICELI R DILEO A ZILEMBO N BUZZONI R SPAGNOLI I MARTINETTI A BICHISAO E SEREGNI E
Citation: E. Bajetta et al., THE AROMATASE INHIBITOR LETROZOLE IN ADVANCED BREAST-CANCER - EFFECTSON SERUM-INSULIN LIKE GROWTH-FACTOR (IGF)-I AND IGF BINDING PROTEIN-3LEVELS, Journal of steroid biochemistry and molecular biology, 63(4-6), 1997, pp. 261-267
A MULTICENTER, RANDOMIZED, PHARMACOKINETIC, ENDOCRINE AND CLINICAL-STUDY TO EVALUATE FORMESTANE IN BREAST-CANCER PATIENTS AT FIRST RELAPSE - ENDOCRINE AND CLINICAL-RESULTS
Authors: BAJETTA E ZILEMBO N BARNI S NOBERASCO C MARTINETTI A FERRARI L SCHIEPATTI G BUZZONI R JIRILLO A AMICHETTI M DAPRILE M COMELLA G BICHISAO E BOLELLI GF ATTILI A BOMBARDIERI E
Citation: E. Bajetta et al., A MULTICENTER, RANDOMIZED, PHARMACOKINETIC, ENDOCRINE AND CLINICAL-STUDY TO EVALUATE FORMESTANE IN BREAST-CANCER PATIENTS AT FIRST RELAPSE - ENDOCRINE AND CLINICAL-RESULTS, Annals of oncology, 8(7), 1997, pp. 649-654
DOUBLE-BLIND, MULTICENTER, RANDOMIZED TRIAL TO COMPARE THE EFFECT OF 2 DOSES OF ADRENOCORTICOTROPIC HORMONE VERSUS PLACEBO IN CONTROLLING DELAYED EMESIS AFTER HIGH-DOSE CISPLATIN IN ADULT PATIENTS WITH CANCER
Authors: PASSALACQUA R COCCONI G CAMINITI C SILINGARDI V BELLA MA BICHISAO E MICHIARA M MALAVASI V DONATI D DICOSTANZO F ROCCA A DISARRA S SCAGLIONE F FRASCHINI F
Citation: R. Passalacqua et al., DOUBLE-BLIND, MULTICENTER, RANDOMIZED TRIAL TO COMPARE THE EFFECT OF 2 DOSES OF ADRENOCORTICOTROPIC HORMONE VERSUS PLACEBO IN CONTROLLING DELAYED EMESIS AFTER HIGH-DOSE CISPLATIN IN ADULT PATIENTS WITH CANCER, Journal of clinical oncology, 15(6), 1997, pp. 2467-2473
NOVEL NONSTEROIDAL AROMATASE INHIBITORS - ARE THERE NEW PERSPECTIVES IN THE TREATMENT OF BREAST-CANCER
Authors: BAJETTA E CELIO L BUZZONI R BICHISAO E
Citation: E. Bajetta et al., NOVEL NONSTEROIDAL AROMATASE INHIBITORS - ARE THERE NEW PERSPECTIVES IN THE TREATMENT OF BREAST-CANCER, Tumori, 82(5), 1996, pp. 417-422
HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS
Authors: ZILEMBO N BAJETTA E NOBERASCO C VICARIO G BICHISAO E DAPRILE M
Citation: N. Zilembo et al., HORMONAL-THERAPY IN PATIENTS WITH STAGE-IV BREAST-CANCER AT DIAGNOSIS, Oncology Reports, 2(4), 1995, pp. 601-602
FORMESTANE - AN EFFECTIVE FIRST-LINE ENDOCRINE TREATMENT FOR ADVANCEDBREAST-CANCER
Authors: ZILEMBO N BAJETTA E NOBERASCO C BUZZONI R VICARIO G BONO A LAFFRANCHI A BIASI G DOLCI S BICHISAO E
Citation: N. Zilembo et al., FORMESTANE - AN EFFECTIVE FIRST-LINE ENDOCRINE TREATMENT FOR ADVANCEDBREAST-CANCER, Journal of cancer research and clinical oncology, 121(6), 1995, pp. 378-382
ACTIVITY OF FORMESTANE IN DE-NOVO TAMOXIFEN-RESISTANT PATIENTS WITH METASTATIC BREAST-CANCER
Authors: NOBERASCO C BAJETTA E ZILEMBO N DILEO A CAPPUZZO F BARTOLI C BONO A BICHISAO E
Citation: C. Noberasco et al., ACTIVITY OF FORMESTANE IN DE-NOVO TAMOXIFEN-RESISTANT PATIENTS WITH METASTATIC BREAST-CANCER, Oncology, 52(6), 1995, pp. 454-457
EFFICACY AND TOLERABILITY OF 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 1ST-LINE TREATMENT IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER AFTER ADJUVANT THERAPY
Authors: BAJETTA E ZILEMBO N BUZZONI R NOBERASCO C CELIO L BICHISAO E
Citation: E. Bajetta et al., EFFICACY AND TOLERABILITY OF 4-HYDROXYANDROSTENEDIONE (4-OHA) AS 1ST-LINE TREATMENT IN POSTMENOPAUSAL PATIENTS WITH BREAST-CANCER AFTER ADJUVANT THERAPY, Cancer treatment reviews, 19, 1993, pp. 31-36
Risultati: 1-10 |